ArticleCurrent oncology (Toronto, Ont.)2014

Gemcitabine-based regimen for primary ovarian angiosarcoma with MYC amplification.

I Yonezawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.